Literature DB >> 26924727

Sensitive periods and language in cochlear implant users.

Ignacio Moreno-Torres1, Sonia Madrid-Cánovas2, Gema Blanco-Montañez3.   

Abstract

This study explores the hypothesis that the existence of a short sensitive period for lower-level speech perception/articulation skills, and a long one for higher-level language skills, may partly explain the language outcomes of children with cochlear implants (CIs). The participants were fourteen children fitted with a CI before their second birthday. Data about their language skills and the environmental conditions (e.g. Family Involvement in rehabilitation) were obtained over a period of three years. Age at implantation correlated exclusively with the ratio of errors of place of articulation, a phonological feature for which CIs provide insufficient information. The degree of Family Involvement was significantly correlated with the remaining language measures. We conclude that small plasticity reductions affecting lower-level skills may partly explain the difficulties of some CI users in developing language.

Entities:  

Mesh:

Year:  2016        PMID: 26924727     DOI: 10.1017/S0305000915000823

Source DB:  PubMed          Journal:  J Child Lang        ISSN: 0305-0009


  3 in total

1.  Parenting Stress, Self-Efficacy, and Involvement: Effects on Spoken Language Ability Three Years After Cochlear Implantation.

Authors:  Ivette Cejas; Christine M Mitchell; David H Barker; Christina Sarangoulis; Laurie S Eisenberg; Alexandra L Quittner
Journal:  Otol Neurotol       Date:  2021-12-01       Impact factor: 2.311

2.  Candidacy for Cochlear Implantation in Prelingual Profoundly Deaf Adult Patients.

Authors:  Ghizlene Lahlou; Hannah Daoudi; Evelyne Ferrary; Huan Jia; Marion De Bergh; Yann Nguyen; Olivier Sterkers; Isabelle Mosnier
Journal:  J Clin Med       Date:  2022-03-28       Impact factor: 4.241

3.  Diversity of Child and Family Characteristics of Children with Hearing Loss in Family-Centered Early Intervention in The Netherlands.

Authors:  Rosanne B van der Zee; Evelien Dirks
Journal:  J Clin Med       Date:  2022-04-07       Impact factor: 4.964

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.